Clinical Trials Directory

Trials / Sponsors / Clementia Pharmaceuticals Inc.

Clementia Pharmaceuticals Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Tre
Fibrodysplasia Ossificans Progressiva
Phase 22021-12-01
CompletedStudy Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on
Fibrodysplasia Ossificans Progressiva
Phase 12019-01-03
CompletedStudy to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarot
Dry Eye Disease
Phase 12018-08-30
TerminatedAn Efficacy and Safety Study of Palovarotene for the Treatment of MO
Exostoses, Multiple Hereditary
Phase 22018-03-22
CompletedAn Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.
Fibrodysplasia Ossificans Progressiva
Phase 32017-11-30
TerminatedIn-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) S
Fibrodysplasia Ossificans Progressiva
Phase 22015-12-07
CompletedStudy to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in He
FOP
Phase 12015-09-01
CompletedA Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
Fibrodysplasia Ossificans Progressiva
—2014-12-18
CompletedAn Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
Fibrodysplasia Ossificans Progressiva
Phase 22014-10-09
CompletedAn Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Fibrodysplasia Ossificans Progressiva
Phase 22014-07-14